相关实验视频
Updated: Sep 20, 2025
05:17
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
Published on: April 18, 2025
371
一个简短的Aβ成像的历史
Ann D Cohen1, Victor L Villemagne1
1Department of Psychiatry, The University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
概括
β-粉样蛋白 (Aβ) 成像已经改变了阿尔茨海默病 (AD) 的评估,为Aβ病理提供了精确的见解. 这种技术对于诊断,分期和评估新的Aβ向疗法至关重要.
科学领域:
- 神经成像是一种神经成像.
- 神经病理学神经病理学
- 阿尔茨海默氏症疾病研究研究
背景情况:
- β-粉样蛋白 (Aβ) 病理是阿尔茨海默病 (AD) 的一个标志.
- 在体内对Aβ病理的评估历来一直具有挑战性.
- 了解Aβ沉积的时间动态对于AD至关重要.
研究的目的:
- 为了突出Aβ成像对AD评估的革命性影响.
- 强调Aβ成像的诊断和治疗评估能力.
- 强调Aβ成像在了解疾病进展中的作用.
主要方法:
- 使用体内成像对区域和全球Aβ负担的定量评估.
- 纵向研究将Aβ成像与其他生物标志物相关联.
- 分析Aβ沉积与临床症状和疾病阶段关系的分析.
主要成果:
- Aβ成像提供了关于Aβ负担的准确,可靠和可重复的定量数据.
- 正如纵向研究表明的,Aβ沉积在症状出现前几十年就开始了.
- Aβ成像对于差异诊断,分期和评估抗Aβ疗法至关重要.
结论:
- Aβ成像已经从根本上改变了AD Aβ病理的体内评估.
- 它为Aβ沉积的时间表和程度提供了关键的见解.
- 持续的研究完善了我们对Aβ作用及其与其他生物标志物的关系的理解.
更多相关视频
08:25Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease
Published on: April 19, 2021
3.5K
09:31Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
Published on: March 7, 2019
10.8K
相关概念视频
01:26Alzheimer's Disease: Overview
689
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
689
01:14Brain Imaging
325
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
325